Infection prevention company Tristel plc (AIM: TSTL) announced on Monday that it has commercially launched 3T Pro, a premium tier of its 3T digital compliance platform, marking the first paid version of the platform as the company seeks to build recurring digital revenue alongside its infection prevention products.
Previously offered free of charge, the 3T platform supports healthcare providers with staff training management and compliance tracking. Developed by Tristel's in-house software team, 3T Pro adds enhanced asset tracking and lifecycle management, advanced dashboards, structured audit reporting and a scalable data architecture to support future integrations.
The launch introduces a three-tier structure comprising a free entry-level version, a mid-tier combining training management with device traceability, and the premium 3T Pro offering advanced customisation, workflows, reporting and audit readiness. Existing users of traceability features will receive transitional licensing arrangements, while the free entry-level tier will remain available to encourage broad adoption across the healthcare sector.
Active Biotech doses first patient in amended tasquinimod myelofibrosis study
Ipsen's Phase III BOLD trial misses primary endpoint in biliary atresia
Sanofi ends atopic dermatitis development for amlitelimab
ArkBio completes Australian dosing in Phase I trial of influenza AFC drug AK0406
Synaptiq Therapeutics launches and acquires clinical-stage SYN-001 programme
Bio-Thera Solutions reports first patient dosed in Phase 1 study of BAT8013
EU approves AstraZeneca's Etcamah combination for 1st-line ER-positive advanced breast cancer
BeOne Medicines expands US manufacturing with USD300m investment
FDA grants Fast Track designation to Lundbeck's narcolepsy candidate Lu AH69593